on Fresenius Medical Care AG & Co. KGaA (ETR:FME)
Fresenius Medical Care Accelerates Share Buyback Program
On January 9, 2026, Fresenius Medical Care AG announced the continuation of its share buyback program, which was initially disclosed on June 17, 2025. The company plans to buy back a second tranche of shares valued at approximately EUR 415 million, aiming to complete this phase by May 8, 2026. This action is a part of a broader program worth EUR 1 billion. The first tranche was finalized ahead of schedule by December 29, 2025.
The share buyback will take place on the stock exchange, with the primary goal of redeeming the shares and a smaller portion allocated for incentive-based compensation plans. This initiative is supported by an authorization from the company's Annual General Meeting held in May 2021.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Fresenius Medical Care AG & Co. KGaA news